136 related articles for article (PubMed ID: 12383290)
1. A study of intranasal distribution of azelastine hydrochloride aqueous nasal spray with different spray techniques.
Bateman ND; Whymark AD; Clifton NJ; Woolford TJ
Clin Otolaryngol Allied Sci; 2002 Oct; 27(5):327-30. PubMed ID: 12383290
[TBL] [Abstract][Full Text] [Related]
2. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD
Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418
[No Abstract] [Full Text] [Related]
3. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
4. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
[TBL] [Abstract][Full Text] [Related]
5. An endoscopic photographic comparison of nasal drug delivery by aqueous spray.
Homer JJ; Raine CH
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):560-3. PubMed ID: 9884813
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
8. Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis.
Cheng LH; Lee JC; Wu PC; Lin YY; Chu YH; Wang HW
Rhinology; 2019 Aug; 57(4):268-272. PubMed ID: 30887967
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
[TBL] [Abstract][Full Text] [Related]
10. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
Lumry W; Prenner B; Corren J; Wheeler W
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
[TBL] [Abstract][Full Text] [Related]
13. Effects of azelastine nasal spray on nasal and nasopharyngeal microflora.
Aksoy F; Senturk E; Doğan R; Veyseller B; Ozturan O; Gönüllü N; Yilmaz F
J Laryngol Otol; 2016 Jan; 130(1):95-9. PubMed ID: 26515526
[TBL] [Abstract][Full Text] [Related]
14. Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients.
Gawlik R; Jawor B; Rogala B; Parzynski S; DuBuske L
Am J Rhinol Allergy; 2013; 27(6):514-6. PubMed ID: 24274229
[TBL] [Abstract][Full Text] [Related]
15. Azelastine nasal spray for allergic rhinitis.
Med Lett Drugs Ther; 1997 May; 39(1000):45-7. PubMed ID: 9150688
[No Abstract] [Full Text] [Related]
16. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
17. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis.
Han D; Chen L; Cheng L; Liu S; Fu Z; Zhang W; Wang C; Xi L; Zhang L;
ORL J Otorhinolaryngol Relat Spec; 2011; 73(5):260-5. PubMed ID: 21832863
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
Howland WC; Amar NJ; Wheeler W; Sacks H
Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
[TBL] [Abstract][Full Text] [Related]
20. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
